Ezetimibe and Simvastatin Tablets — Class II drug recall D-0228-2022
Terminated recall by Golden State Medical Supply Inc., reported 2021-11-17, distributed in AZ, MO. Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity
| Recall number | D-0228-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Golden State Medical Supply Inc., Camarillo, CA, United States |
| Recall initiated | 2021-10-14 |
| Classified | 2021-11-09 |
| Reported by FDA | 2021-11-17 |
| Terminated | 2022-11-10 |
| Distributed | AZ, MO |
| Quantity | 49 |
| Reason classes | specification failure |
| NDC | 51407-0190, 51407-0190-10, 51407-0190-30, 51407-0190-90, 51407-0191, 51407-0191-10, 51407-0191-30, 51407-0191-90, 51407-0192, 51407-0192-05, 51407-0192-10, 51407-0192-30, 51407-0192-90, 51407-0193, 51407-0193-05, 51407-0193-30, 51407-0193-90 |
| Expiration dates | 2023-01 |
Product
Ezetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA 71106 USA, Packaged by GSMS, Incorporated Camarillo, CA 93012 USA; NDC 51407-193-05
Reason for recall
Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0228-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.